AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03553927 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: NHS advice on healthy eating
Description: Advice on energy requirements as per the British Dietetic Association
Study NCT00646789 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Comparator: MK0633
Description: patients will receive single 50mg oral dose with follow-up observation for 5 weeks.
Study NCT04908709 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Spectroscopic Imaging
Description: Undergo sMRI
Study NCT04908709 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Spectroscopic Imaging
Description: Undergo sMRI
Study NCT04908709 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Proton Therapy
Description: Target volume treatment
Study NCT04908709 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Proton Therapy
Description: Target volume treatment
Study NCT03630042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg IV dose given on day 1 of a three week cycle
Study NCT03630042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 IV dose given up to 8 times in the trial
Study NCT01135290 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Aquaphor
Study NCT01135290 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HP828-101
Study NCT03779958 — intervention group
Intervention type: OTHER
Intervention: Mobile App
Description: a mobile app that demonstrates hand therapy exercises
Study NCT02634749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systematic introduction of taste portions
Description: A systematic introduction of plant foods from the Nordic diet
Study NCT02634749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protein reduced complementary foods
Description: Specially prepared, protein-reduced, age-adjusted milk cereal drinks, baby cereals and baby milk, and commercially available baby foods in glass jars
Study NCT02634749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nordic diet
Description: Taste portions, homemade and industry manufactured main meals with a predominance of Nordic ingredients
Study NCT04966052 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05055739 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rigid plate X steel wires
Description: Compare the sternal alignment between the fixation with rigid plate X steel wires.
Study NCT01097330 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ablation
Description: Catheter based radiofrequency ablation for ischemic ventricular tachycardia scheduled to occur within 4 weeks after randomization
Study NCT01097330 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amiodarone
Description: Amiodarone titrated to therapeutic levels as per standard of care and maintained on a dose of at least 200 mg (300 mg recommended) once a day for the duration of the study
Study NCT00769704 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Talimogene laherparepvec
Description: Up to 4 mL of 10⁸ pfu/mL/per intratumoral injection
Study NCT02715401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HCP1303
Study NCT00769704 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GM-CSF
Description: 125 µg/m² subcutaneous injection
Study NCT00326014 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iStent
Description: Glaucoma Surgery
Study NCT02715401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP1201
Study NCT02715401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Study NCT00483262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI-779
Description: Given by injection once a week for 5 weeks (5 weeks equals one cycle) for up to 8 cycles
Study NCT00483262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Given by injection once a week for 4 weeks (a cycle equals 5 weeks) for up to 8 cycles
Study NCT01855308 — intervention group
Intervention type: PROCEDURE
Intervention: Single site robotic chole
Description: Cholecystectomy
Study NCT01855308 — intervention group
Intervention type: DEVICE
Intervention: da Vinci Si Surgical System
Description: minimally invasive robotic surgical system designed to facilitate complex procedures
Study NCT00601640 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac Na gel
Description: Given topically twice daily on days 1-90
Study NCT00601640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac Na gel
Description: Given topically twice daily on days 1-90
Study NCT00601640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eflornithine HCL ointment
Description: Given topically twice daily on days 1-90
Study NCT02359058 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ramucirumab
Description: Administered IV
Study NCT02359058 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Capecitabine
Description: Administered orally
Study NCT02359058 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cisplatin
Description: Administered IV
Study NCT02359058 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: S-1
Description: Administered orally
Study NCT02359058 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oxaliplatin
Description: Administered IV
Study NCT03354533 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: L-fucose
Description: Oral ORL-1F
Study NCT02836678 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ridge splitting, immediate implant, Nanobone with PRF.
Description: * Dental implant (is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis).~* Alloplast bone graft material (Nanobone)~* PRF platelet rich fibrin. (second-generation Platelet rich plasma where autologous platelets and leucocytes are present in a complex fibrin matrix to accelerate the healing of soft and hard tissue).
Study NCT02836678 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Ridge splitting, immediate implantand PRF.
Description: * Dental implant (is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis).~* PRF platelet rich fibrin. (second-generation Platelet rich plasma where autologous platelets and leucocytes are present in a complex fibrin matrix to accelerate the healing of soft and hard tissue).
Study NCT01794377 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 30 minutes of high intensity training
Description: This group will carry out a 5-min warm-up period on bicycle ergometer at an intensity corresponding to 50% of Vo2max before performed eight times the intermittent training exercise as follows:~* 30 sec at 120% of Vo2max,~* 1 min at 50% of Vo2max,~* 15 sec at 30-40 revolutions per minute of strength training at 100% of the maximal anaerobic power, which will be first determined by means of a force-velocity test on a Monark ergometer,~* 1 min at 50% of Vo2max.~The training session will be terminated by a 3-min cool-down period at 40% of Vo2max.~Training three times per week for 5 months under supervision of an exercise physiologist.~Initial nutritional education session at the beginning of the study Questionnaires on training experience during the 5 months training period (Exercise difficulties, pain...).~Dietary Supplement: supplementation in fruits and vegetables (5 per day) during all the study.
Study NCT01794377 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 40 of an endurance training
Description: The moderate-intensity continuous exercise group will carry out a 40-min session of continuous cycling at a moderate intensity (50 % of Vo2max).~Training three times per week for 5 months under supervision of an exercise physiologist.~Initial nutritional education session at the beginning of the study Questionnaires on training experience during the 5 months training period (Exercise difficulties, pain...).~Dietary Supplement: supplementation in fruits and vegetables (5 per day) during all the study.
Study NCT04483843 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention will be performed while it is retrospective observational study.
Study NCT02327039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Sodium glucose cotransporter-2 inhibitor
Study NCT02327039 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tables of Dapagliflozin placebo
Study NCT03848338 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Electrocochleography
Description: Electrocochleography measurement Intra-operatively and Post-operatively at follow-up appointments along with correlative measurements (Impedance, eCAP, PTA, Speech)
Study NCT01696721 — intervention group
Intervention type: OTHER
Intervention: No intervention
Study NCT02955862 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Vietnam Cryptococcal Retention in Care Study (CRICS)
Description: Drug: Fluconazole HIV-infected patients with CD4 ≤100 cells/μL who present for HIV care at outpatient clinics (OPCs) in Vietnam where CrAg screening is offered will be recruited into the study. Study participants will be screened for cryptococcal antigen using the Lateral Flow Assay (LFA). Those who are CrAg-positive, but have no features of central nervous system (CNS) disease, will be treated with high-dose fluconazole.~Other Names:~• Fluconazole
Study NCT02760576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY 987521
Description: Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application.
Study NCT02419521 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Resolute Onyx Stent - 2.25 mm - 4.0 mm
Study NCT04123002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Miswak chewing sticks
Description: Chewing stick are routinely used by this population
Study NCT02922972 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Platelet Rich Plasma obtained with RegenKit®-BCT
Description: After complete resection of the keloid scar, the first injection was administered before closure into the lesion resection bed and edges. Three additional injections were administered with a one-month interval.
Study NCT04637490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: patellar component
Description: patellar resurfacing
Study NCT02748473 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pilates Exercises program
Description: The volunteers were divided in two groups:~Group I: Pilates exercise program involving only the Pilates exercises protocol Group II: Pilates exercises program with voluntary pelvic floor muscle contraction.~The protocol of both groups consisted of 24 bi-weekly 1-h individual sessions of Pilates exercises program.~Both groups performed the same protocol . For the group PEP + PFMC the instructor asked for the maximum contraction muscle of the pelvic floor muscle, during expirations with 5 repetitions performed alternately, thus avoiding pelvic floor muscle exhaustion.~After the 24 sessions, both groups were retested with the same measured methods of the baseline.
Study NCT02748473 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pelvic floor muscle strength
Description: evaluated the pelvic floor strength by oxford scale and vaginal pressure before and after the 12 sessions with Pilates Exercises Program on sedentary nulliparous women
Study NCT02748473 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 3D perineal ultrasound
Description: evaluated the pubovisceral muscle thickness and levator hiatus area by 3D perineal ultrasound before and after the 12 sessions with Pilates Exercises Program on sedentary nulliparous women
Study NCT00812539 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subject/Provider Portal Diabetes Connected Health tool - Deluxe
Description: Subjects enrolled into the Deluxeintervention will use a glucometer, a modem to upload the blood glucose readings to a secure, web-based portal (Diabetes Connected Health tool) where they can view detailed graphical representation of their blood glucose levels over time, educational material regarding diabetes management and receive personalized tips and feedback from their physicians (who will also have access to their subjects' information on the web portal and contact them by an embedded messaging system). Subjects with new high or low readings will be flagged. Providers can initiate messages to subjects regarding symptoms or medications. A medication summary and log of all readings uploaded with date/time will be displayed on the website as well as a graphical display of all uploaded glucose readings over time and will allow subjects to enter comments regarding each critical reading.
Study NCT00812539 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Subject only Portal Diabetes Connected Health Tool Basic
Description: Patients enrolled in the Diabetes Connect Basic intervention will use a glucometer, a modem which will upload the blood glucose readings to a secure, web-based portal (the Diabetes Connected Health tool) where they can view their readings in a less detailed/journal fashion. No detailed graphical representation of their blood glucose levels over time is available to this group, nor is any educational material regarding diabetes management. Their physicians will not have access to these subjects' information on the web portal and will not have the ability to contact them by an embedded messaging system.
Study NCT02248142 — intervention group
Intervention type: DRUG
Intervention: Pramipexole
Study NCT03956199 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulpotomy
Description: removal of the pulp from pulp chamber
Study NCT03956199 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root canal treatment
Description: Removal of at the entire content of the root canal system and root canal obturation
Study NCT03277157 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: B. lactis B94
Description: A probiotic dose of 15 billion per capsule.
Study NCT03277157 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule
Study NCT04603716 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eccentric Muscle Energy Technique
Description: Conventional Treatment given to both groups (Hot pack for 15 minutes, Mobilization, AROM Exercises 10 sets x 3days in a week)~Reciprocal inhibition of target muscle (i.e. levator scapulae ,pectoralis major, upper trapezius) causing relaxation, patient force is minimal towards maximal therapist force, 5-7 repetition for 2-4seconds 3 days in a week up to 6 weeks.~Muscle is taken from shortened to lengthened position.
Study NCT03084861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cord Blood Eye Drops
Description: Eye drops plasma from cord blood diluted v/v with Plasmalyte®, without antimicrobial preservatives
Study NCT03084861 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: 1. Artificial tears: Lubristil ®~2. Therapeutic Contact lens: Air Optix Night\&Day
Study NCT00587132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin
Description: 0.2mcg/kg one time dose.
Study NCT01339702 — intervention group
Intervention type: OTHER
Intervention: The National Prehospital TBI Management Guidelines
Description: In the post-implementation (after) cohort, implementation of the entire bundle of the TBI treatment guidelines with special emphasis on prevention and treatment of hypotension (IV crystalloids), prevention and treatment of hypoxia (pre-oxygenation with high-flow O2 via non-rebreather mask, bag-valve-mask, extraglottic airways/intubation when basic maneuvers have failed), and prevention of hyperventilation (in intubated patients) and prevention/treatment of hypoventilation (in all patients).
Study NCT03018145 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wagon
Study NCT03018145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard stretcher car
Study NCT01380119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V7
Description: experimental arm
Study NCT01380119 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo pill
Study NCT01878890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 600mg
Description: Efavirenz 600 mg (oral daily intake)
Study NCT01878890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 1200 mg
Description: Efavirenz 1200mg (oral daily intake)
Study NCT01878890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 1800 mg
Description: Efavirenz 1800mg (oral daily intake)
Study NCT01878890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz 2200 mg
Description: Efavirenz 2200mg (oral daily intake)
Study NCT03431779 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adipose derived stem cell transplantation via lipofilling
Description: Liposuction of 60cc abdominal fat with its adipose derived stem cells which will be reinjected (10-20 cc) in the vestibular area after centrifugation for 3 minutes at 1000 rpm and decantation of oil and red blood cells.
Study NCT04603716 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concentric muscle energy technique
Description: Group B: Concentric Muscle Energy Technique: (Autogenic inhibition of target muscle (i.e. levator scapulae ,pectoralis major, upper trapezius) patient force is greater than therapist force, 5-7repitition for 3-4seconds)Muscle is taken from lengthened to shortened position.~On eligible participants baseline assessment was done,3 session were given 3days per week, post intervention assessment was taken at 1st 3rd and 6th week
Study NCT04549961 — intervention group
Intervention type: OTHER
Intervention: Nutrition
Description: type and amount of food eaten or type and amount of oral nutritional supplements as well as enteral or parenteral nutrition
Study NCT03431779 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical excision
Description: Excision of painful areas
Study NCT02952261 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: template-guided localization
Description: Based on CT data, digital model of the navigational template was created using CAD software and imported to 3D printer. The navigational template serves as a guider to the localizer in lung nodule localization.
Study NCT02952261 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CT-guided localization
Description: Percutaneous lung nodule localization was conducted under the real-time guidance of CT scan. This is the conventional method of transthoracic lung nodule localization.
Study NCT00310362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Description: Interactive voice response system (IVR) calls patients 7 or 3 days prior to their appointment. Information available in the IVR system is based on the same template nurses use in usual care and includes an appointment reminder, preparation instructions, basic information about the procedure, and answers to commonly asked questions.
Study NCT02772055 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moxibustion
Description: Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.
Study NCT02772055 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moxa smoke purification device
Description: Investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200 moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the moxa smoke.
Study NCT02890095 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Breast cancer surgery
Description: First, 2 specific adipose tissue samples will be performed during the surgery :~* 1 sample near the tumor, to measure the contaminants (dioxins, PCBs, organochlorine pesticides, polybrominated compounds)~* 1 remote sample of the tumor bed, superficial, at least 5 cm from the tumor, to be used to determine the level of expression of hormone receptors and to establish the expression profiles, after cutting and inclusion in paraffin blocks for marking IHC.~These withdrawals are made during surgery, during surgery, as part of the intervention and the remodeling of the mammary gland (standard care for patients). This is unused balance for diagnostic.~Before anaesthesia : specific blood samples (for the determination of circulating pollutants and for the analysis of gene polymorphism)
Study NCT02890095 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: plastic surgery
Description: The excision piece will follow the classical pathological circuit.~A specific charge of subcutaneous adipose tissue will be performed as part of research on the surgical specimen. This sample will be used:~* measuring contaminants (dioxins, PCBs, organochlorine pesticides, polybrominated compounds)~* to determine the level of expression of hormone receptors and to establish the expression profiles, after cutting and inclusion in paraffin blocks for marking IHC. These samples are all made during surgery, for usual care surgery these patients.~Before anaesthesia : specific blood samples (for the determination of circulating pollutants and for the analysis of gene polymorphism)
Study NCT04616482 — intervention group
Intervention type: BEHAVIORAL
Intervention: Digital therapeutic carbohydrate restriction (TCR) program
Description: A 12-week, personalized, online program to teach and coach patients about therapeutic carbohydrate restriction as for obesity and/or T2D (or risk of T2D). The program is intended to enhance the usual clinical care provided for patients.